Differential effects of the enantiomers R(−) and S(+) oxaprotiline on major endogenous depression, the sleep EEG and neuroendocrine secretion: Studies on depressed patients and normal controls
- 1 June 1993
- journal article
- clinical trial
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 3 (2) , 117-126
- https://doi.org/10.1016/0924-977x(93)90263-l
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- The effect of (+)- and (−)-oxaprotiline administered repeatedly on the dopamine systemJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1991
- Oxaprotiline enantiomers given repeatedly and brain α-adrenoceptorsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1990
- The influence of repeated treatment with imipramine, (+)- and (?)-oxaprotiline on behavioural effects of dopamine D-1 and D-2 agonistsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1989
- CGP 12.103 A Versus Clomipramine in the Treatment of Depressed Inpatients - Results of a Double-Blind StudyPharmacopsychiatry, 1988
- Results of an Open Clinical Trial of Brofaromine (CGP 11 305 A), a Competitive, Selective, and Short-Acting Inhibitor of MAO-A in Major Endogenous DepressionPharmacopsychiatry, 1987
- Neurotransmitter modulation of corticotropin releasing factor secretion into the hypophysial-portal circulationLife Sciences, 1987
- (+)-Oxaprotiline but not (-)-oxaprotiline given chronically potentiates the aggressive behaviour induced by clonidineJournal of Pharmacy and Pharmacology, 1983
- Oxaprotiline: Induction of central noradrenergic subsensitivity by its (+)-enantiomerLife Sciences, 1982
- Reversible Loss of Nocturnal Penile Tumescence during Depression: A Preliminary ReportNeuropsychobiology, 1982
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960